Optimi Health Corp. (OPTH:NASDAQ) closed at $2.15 on November 16, 2026, down 4.44% on the day. The stock trades 66.4% below its 52-week high of $6.40 and 13.2% above its 52-week low of $1.90. Over the past year, it lost 64.6%. Optimi Health Corp. is part of the Health Care sector.
In 124 trading sessions since May 21, 2026, OPTH closed higher on 50 days (40%). Its best day was June 18, 2026 (+15.37%) and its worst was June 5, 2026 (-17.73%). The stock moved 10% or more in a single session 11 times.
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) is a leading producer of prescribed psychedelic treatments for mental health therapies. As a Health Canada-licensed, GMP compliant pharmaceutical manufacturer producing validated MDMA and botanical psilocybin products from two 10,000-square-foot facilities in British Columbia, Optimi supplies active pharmaceutical ingredients and finished dosage forms to regulated channels, with products currently in market for prescription use in Australia via the Authorized Prescriber Scheme and accessible in Canada through the Special Access Program.
Find more stocks like OPTH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.